Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Mouse Common gamma Chain/IL-2 R gamma Biotinylated Antibody, R&D Systems™

Goat Polyclonal Antibody
Supplier: R&D Systems BAF784
This item is not returnable.
View return policy
Description
Common gamma Chain/IL-2 R gamma Polyclonal specifically detects Common gamma Chain/IL-2 R gamma in Mouse samples. It is validated for Western Blot.Specifications
Common gamma Chain/IL-2 R gamma | |
Polyclonal | |
Biotin | |
P34902 | |
Il2rg | |
S. frugiperda insect ovarian cell line Sf 21-derived recombinant mouse Common gamma Chain/IL-2 R gamma Met1-Ala263 Accession # P34902 | |
50 μg | |
Primary | |
Detects mouse Common gamma Chain/IL-2 R gamma in Western blots. In Western blots, approximately 5% cross-reactivity with recombinant human (rh) IL-2 R gamma is observed and less than 1% cross-reactivity with rhIL-2 R alpha , recombinant mouse IL-2 R beta , and rhIL-15 R is observed. | |
Mouse | |
IgG |
Western Blot | |
LYOPH | |
Western Blot 0.1 ug/mL | |
CD132, CD132 antigen, CIDX, combined immunodeficiency, X-linked, common cytokine receptor gamma chain, common gamma-chain, cytokine receptor common subunit gamma, gamma(c), IL-2 R gamma, IL-2 receptor subunit gamma, IL2R gamma, IL-2R subunit gamma, IL2RG, IL-2RG, IMD4, interleukin 2 receptor, gamma, Interleukin-2 receptor subunit gamma, p64, SCIDX, SCIDX1, severe combined immunodeficiency | |
Goat | |
Affinity Purified | |
RUO | |
3561 | |
Reconstitute at 0.2 mg/mL in sterile PBS. | |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution. |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction